Adalimumab in Focus: Evaluating Effectiveness and Safety in Non-Infectious Uveitis at a Tertiary Referral Center in Türkiye

Berru Yargı Özkoçak; Çiğdem Altan; Burcu Kemer Atik; Berna Başarır

doi:10.4274/tjo.galenos.2025.67513

August 21, 2025Turkish Journal of OphthalmologyOpen Access

Adalimumab in Focus: Evaluating Effectiveness and Safety in Non-Infectious Uveitis at a Tertiary Referral Center in Türkiye

View Full Paper

Ask AI

Bookmark

Share

Key Points

Adalimumab was found effective for managing non-infectious uveitis symptoms, and overall safety profiles were satisfactory.
The study observed a significant improvement in patients, indicating potential benefits in reducing disease activity.
Real-world data was collected at a tertiary referral center, enhancing the validity of findings in a clinical context.
These implications support broader use of adalimumab in treating non-infectious uveitis among Turkish patients.

Implication

Analysis assesses efficacy and safety of adalimumab in active non-infectious uveitis, suggesting treatment potential.

Abstract

To evaluate the indications, efficacy, and safety of adalimumab (ADA) in treating active non-infectious uveitis (NIU) in the Turkish population in a real-world setting.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Özkoçak et al. (2025) studied this question.

synapsesocial.com/papers/68c1cc4054b1d3bfb60f4bfe https://doi.org/10.4274/tjo.galenos.2025.67513

View Full Paper

Ask AI

Bookmark

Share

Adalimumab in Focus: Evaluating Effectiveness and Safety in Non-Infectious Uveitis at a Tertiary Referral Center in Türkiye

Key Points

Implication

Abstract

Discussion

Cite This Study

Adalimumab in Focus: Evaluating Effectiveness and Safety in Non-Infectious Uveitis at a Tertiary Referral Center in Türkiye

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading